215 related articles for article (PubMed ID: 8887044)
21. Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms.
Nagashio Y; Hijioka S; Mizuno N; Hara K; Imaoka H; Bhatia V; Niwa Y; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Yamao K
Pancreatology; 2014; 14(6):503-9. PubMed ID: 25458668
[TBL] [Abstract][Full Text] [Related]
22. Hepatobiliary mucinous cystadenoma and cystadenocarcinoma: report of six cases and review of the literature.
Yu J; Wang Y; Yu X; Liang P
Hepatogastroenterology; 2010; 57(99-100):451-5. PubMed ID: 20698207
[TBL] [Abstract][Full Text] [Related]
23. The importance of cyst fluid analysis for differentiation of pancreatic cyst.
Inan M; Besim H; Serhat H; Büyük S
Acta Chir Belg; 2008; 108(3):350-3. PubMed ID: 18710114
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management.
Leung KK; Ross WA; Evans D; Fleming J; Lin E; Tamm EP; Lee JH
Ann Surg Oncol; 2009 Oct; 16(10):2818-24. PubMed ID: 19536601
[TBL] [Abstract][Full Text] [Related]
25. Hepatic cystic mass with a daughter cyst: a feature of mucinous cystadenoma.
Verbeeck N; Hoebeke Y
J Belge Radiol; 1997 Jun; 80(3):113-5. PubMed ID: 9260391
[TBL] [Abstract][Full Text] [Related]
26. [Cystadenoma of the liver with high levels of ACE and CA 19-9 in the cyst].
Trésallet C; Jordi-Galais P; Nguyen-Thanh Q; Aubriot-Lorton MH; Costedoat-Chalumeau N; Chigot JP; Menegaux F
Gastroenterol Clin Biol; 2003 Apr; 27(4):413-5. PubMed ID: 12759683
[TBL] [Abstract][Full Text] [Related]
27. Duodenal duplication cyst with profound elevation of intracystic carbohydrate antigen (CA 19-9) and carcinoembryonic antigen (CEA): a rare but important differential in the diagnosis of cystic tumours of the pancreas.
Shah KJ; Malleo G; Low J; Skordilis K; Makin AJ; Siriwardena AK
JOP; 2006 Mar; 7(2):200-4. PubMed ID: 16525204
[TBL] [Abstract][Full Text] [Related]
28. Biliary mucinous cystic neoplasm mimicking a hydatid cyst: a case report and literature review.
Tholomier C; Wang Y; Aleynikova O; Vanounou T; Pelletier JS
BMC Gastroenterol; 2019 Jun; 19(1):103. PubMed ID: 31234803
[TBL] [Abstract][Full Text] [Related]
29. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts.
Sperti C; Pasquali C; Pedrazzoli S; Guolo P; Liessi G
Am J Gastroenterol; 1997 Apr; 92(4):672-5. PubMed ID: 9128321
[TBL] [Abstract][Full Text] [Related]
30. Role of tumor markers in the diagnosis of cystic and intraductal neoplasms.
Hammel P
Gastrointest Endosc Clin N Am; 2002 Oct; 12(4):791-801. PubMed ID: 12607788
[TBL] [Abstract][Full Text] [Related]
31. Hepatobiliary cystadenocarcinoma with cystadenoma elements of the gall bladder in an old man.
Terada T; Takeuchi T; Taniguchi M
Pathol Int; 2003 Nov; 53(11):790-5. PubMed ID: 14629305
[TBL] [Abstract][Full Text] [Related]
32. [Cystic teratoma of the pancreas].
Rivkine E; Goasguen N; Chelbi E; Couvelard A; Vullierme MP; Vilgrain V; Hammel P; Sauvanet A
Gastroenterol Clin Biol; 2007 Nov; 31(11):1016-9. PubMed ID: 18166898
[TBL] [Abstract][Full Text] [Related]
33. Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma.
Wu H; Yan LN; Cheng NS; Zhang YG; Ker CG
Hepatogastroenterology; 2007; 54(79):1915-8. PubMed ID: 18251127
[TBL] [Abstract][Full Text] [Related]
34. Serum and cystic fluid CA 19-9 determinations as a diagnostic help in liver cysts of uncertain nature.
Horsmans Y; Laka A; Gigot JF; Geubel AP
Liver; 1996 Aug; 16(4):255-7. PubMed ID: 8877996
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic resection of a benign true cyst of the spleen with the harmonic scalpel producing high levels of CA 19-9 and carcinoembryonic antigen.
Sardi A; Ojeda HF; King D
Am Surg; 1998 Dec; 64(12):1149-54. PubMed ID: 9843333
[TBL] [Abstract][Full Text] [Related]
36. CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy.
Lee DW; Im SA; Kim YJ; Yang Y; Rhee J; Na II; Lee KH; Kim TY; Han SW; Choi IS; Oh DY; Kim JH; Kim TY; Bang YJ
Cancer Res Treat; 2017 Jul; 49(3):807-815. PubMed ID: 28111425
[TBL] [Abstract][Full Text] [Related]
37. Carbohydrate 19-9 antigen as a marker of non-malignant hepatocytic ductular transformation in patients with acute liver failure. A comparison with alpha-fetoprotein and carcinoembryonic antigen.
Halme L; Kärkkäinen P; Isoniemi H; Mäkisalo H; von Bogulawski K; Höckerstedt K
Scand J Gastroenterol; 1999 Apr; 34(4):426-31. PubMed ID: 10365905
[TBL] [Abstract][Full Text] [Related]
38. Cyst fluid analysis to diagnose pancreatic cystic lesions: an as yet unfulfilled promise.
Pelaez-Luna M; Chari ST
Gastroenterology; 2006 Mar; 130(3):1007-9; discussion 1009. PubMed ID: 16530543
[No Abstract] [Full Text] [Related]
39. Diagnosis and treatment of hepatic cysts. Usefulness of intracystic tumor markers (CEA and CA 19.9.).
Polette D; Mils K; López-Domínguez F; Barrios O; Leiva D; Puig I; Ramos E; Lladó L
Cir Esp (Engl Ed); 2024 Jan; 102(1):19-24. PubMed ID: 37980963
[TBL] [Abstract][Full Text] [Related]
40. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]